2. Signaling Pathways
  3. GPCR/G Protein
    Neuronal Signaling
  4. Somatostatin Receptor
  5. Somatostatin Receptor Isoform
  6. Somatostatin Receptor Inhibitor

Somatostatin Receptor Inhibitor

Somatostatin Receptor Inhibitors (18):

Cat. No. Product Name Effect Purity
  • HY-RS13822
    Sstr1 Rat Pre-designed siRNA Set A
    		Inhibitor

    Sstr1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Sstr1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
  • HY-RS13830
    Sstr4 Mouse Pre-designed siRNA Set A
    		Inhibitor

    Sstr4 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Sstr4 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
  • HY-RS13820
    SSTR1 Human Pre-designed siRNA Set A
    		Inhibitor

    SSTR1 Human Pre-designed siRNA Set A contains three designed siRNAs for SSTR1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
  • HY-RS13821
    Sstr1 Mouse Pre-designed siRNA Set A
    		Inhibitor

    Sstr1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Sstr1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
  • HY-RS13824
    Sstr2 Mouse Pre-designed siRNA Set A
    		Inhibitor

    Sstr2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Sstr2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
  • HY-RS13828
    Sstr3 Rat Pre-designed siRNA Set A
    		Inhibitor

    Sstr3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Sstr3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
  • HY-RS13834
    Sstr5 Rat Pre-designed siRNA Set A
    		Inhibitor

    Sstr5 Rat Pre-designed siRNA Set A contains three designed siRNAs for Sstr5 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
  • HY-RS13827
    Sstr3 Mouse Pre-designed siRNA Set A
    		Inhibitor

    Sstr3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Sstr3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
  • HY-RS13826
    SSTR3 Human Pre-designed siRNA Set A
    		Inhibitor

    SSTR3 Human Pre-designed siRNA Set A contains three designed siRNAs for SSTR3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
  • HY-RS13831
    Sstr4 Rat Pre-designed siRNA Set A
    		Inhibitor

    Sstr4 Rat Pre-designed siRNA Set A contains three designed siRNAs for Sstr4 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
  • HY-142929
    MAT2A-IN-2
    		Inhibitor
    MAT2A-IN-2 is a potent inhibitor of MAT2A. The expression level of MAT2A is abnormally high in several types of tumors, including gastric, colon, liver and pancreatic cancers. MAT2A-IN-2 reduces the proliferative activity of MTAP-deficient cancer cells. MAT2A-IN-2 has the potential for the research of cancer diseases (extracted from patent WO2020243376A1, compound 172).
  • HY-RS13825
    Sstr2 Rat Pre-designed siRNA Set A
    		Inhibitor

    Sstr2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Sstr2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
  • HY-RS13833
    Sstr5 Mouse Pre-designed siRNA Set A
    		Inhibitor

    Sstr5 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Sstr5 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.
  • HY-142928
    MAT2A-IN-1
    		Inhibitor
    MAT2A-IN-1 is a potent inhibitor of MAT2A. The expression level of MAT2A is abnormally high in several types of tumors, including gastric, colon, liver and pancreatic cancers. MAT2A-IN-1 reduces the proliferative activity of MTAP-deficient cancer cells. MAT2A-IN-1 has the potential for the research of cancer diseases (extracted from patent WO2021139775A1, compound 64).
  • HY-142930
    MAT2A-IN-3
    		Inhibitor
    MAT2A-IN-3 is a potent inhibitor of MAT2A. The expression level of MAT2A is abnormally high in several types of tumors, including gastric, colon, liver and pancreatic cancers. MAT2A-IN-3 reduces the proliferative activity of MTAP-deficient cancer cells. MAT2A-IN-3 has the potential for the research of cancer diseases (extracted from patent WO2019191470A1, compound 265).
  • HY-RS13832
    SSTR5 Human Pre-designed siRNA Set A
    		Inhibitor

    SSTR5 Human Pre-designed siRNA Set A contains three designed siRNAs for SSTR5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
  • HY-RS13829
    SSTR4 Human Pre-designed siRNA Set A
    		Inhibitor

    SSTR4 Human Pre-designed siRNA Set A contains three designed siRNAs for SSTR4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
  • HY-RS13823
    SSTR2 Human Pre-designed siRNA Set A
    		Inhibitor

    SSTR2 Human Pre-designed siRNA Set A contains three designed siRNAs for SSTR2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.